Evaluation of Pharmacist-Based Services for Type 2 Diabetes Mellitus in the Indonesian Community Health Centers
Abstract
Introduction: Diabetes mellitus is a global epidemic that continues to rise, including in Indonesia, and it has significant impacts on public health. The role of pharmacists in providing pharmaceutical care for diabetic patients in community health centers is crucial, yet challenges in its implementation persist. However, in-depth studies on pharmacists' practice experiences in this context are still limited in Indonesia. This study aimed to explore pharmacists' experiences in implementing pharmaceutical care for diabetic patients at community health centers in Indonesia.
Methods: The cross-sectional study was conducted in community health centers in South Kalimantan Province, Indonesia. Pharmacists practicing at community health centers were recruited between October and December 2023. The survey was distributed in both paper and online (Google Form) formats. The questionnaire used in the survey focused on the provision of assessment, care plan, and follow-up parameters regarding the medication of diabetic patients.
Results: A response rate of 60,3% (n=143) was obtained from pharmacists involved in this survey. Regarding the assessment parameter, the indicator of assessment patient trust was the most dominant implemented by pharmacists (93,7%) compared to other indicators. In terms of the care plan parameter, providing information on medication indications was the most dominant indicator implemented (82,9%). Meanwhile, for the follow-up parameter, the indicator of medication adherence follow-up was the most dominantly implemented by pharmacists (79,1%). Factor analysis revealed that assessment, care plan, and follow-up evaluation each constituted one composite.
Conclusion: The pharmaceutical care provided by pharmacists at community health centers for diabetic patients is still suboptimal. The factors that caused the suboptimal implementation of pharmaceutical care were resource limitations, inadequate specialized training for pharmacists, and insufficient support from the healthcare system.
References
Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation. Int J Mol Sci. 2020;21(5).
Kostov K. Effects of Magnesium Deficiency on Mechanisms of Insulin Resistance in Type 2 Diabetes: Focusing on the Processes of Insulin Secretion and Signaling. Int J Mol Sci. 2019;20(6).
Pertiwi MV, Alfian R, Nita Y, Athiyah U. Medication adherence of diabetes mellitus patients in Indonesia: A systematic review. Pharmacy Education. 2022:188-93.
Patty Y, Mufarrihah, Nita Y. Cost of illness of diabetes mellitus in Indonesia: a systematic review. J Basic Clin Physiol Pharmacol. 2021;32(4):285-95.
Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health. 2020;10(1):107-11.
Balooch Hasankhani M, Mirzaei H, Karamoozian A. Global trend analysis of diabetes mellitus incidence, mortality, and mortality-to-incidence ratio from 1990 to 2019. Sci Rep. 2023;13(1):21908.
IDF. IDF Diabetes Atlas 10th edition: International Diabetes Federation; 2021.
Jia W, Weng J, Zhu D, Ji L, Lu J, Zhou Z, et al. Standards of medical care for type 2 diabetes in China 2019. Diabetes Metab Res Rev. 2019;35(6):e3158.
Reddy M, Oliver N. The role of real-time continuous glucose monitoring in diabetes management and how it should link to integrated personalized diabetes management. Diabetes Obes Metab. 2024;26 Suppl 1:46-56.
Alfian R, Athiyah U, Nita Y. Social media health interventions to improve diabetes mellitus patient outcome: a systematic review. J Basic Clin Physiol Pharmacol. 2021;32(4):297-304.
Dilles T, Heczkova J, Tziaferi S, Helgesen AK, Grondahl VA, Van Rompaey B, et al. Nurses and Pharmaceutical Care: Interprofessional, Evidence-Based Working to Improve Patient Care and Outcomes. International journal of environmental research and public health. 2021;18(11).
Dockendorf MF, Hansen BJ, Bateman KP, Moyer M, Shah JK, Shipley LA. Digitally Enabled, Patient-Centric Clinical Trials: Shifting the Drug Development Paradigm. Clin Transl Sci. 2021;14(2):445-59.
Kharaba Z, Farhat J, Mahboub BS, Buabeid MA, Alfoteih Y, Al-Worafi Y, et al. Current views of community and hospital pharmacists on pharmaceutical care services in the United Arab Emirates: A mixed methodological study. F1000Res. 2022;11:694.
Ilardo ML, Speciale A. The Community Pharmacist: Perceived Barriers and Patient-Centered Care Communication. International journal of environmental research and public health. 2020;17(2).
Lima TM, Aguiar PM, Storpirtis S. Evaluation of quality indicator instruments for pharmaceutical care services: A systematic review and psychometric properties analysis. Res Social Adm Pharm. 2018;14(5):405-12.
Moltó-Puigmartà C, Vonk R, van Ommeren G, Hegger I. A logic model for pharmaceutical care. Journal of Health Services Research & Policy. 2018;23(3):148-57.
Hazen ACM, de Bont AA, Leendertse AJ, Zwart DLM, de Wit NJ, de Gier JJ, et al. How Clinical Integration of Pharmacists in General Practice has Impact on Medication Therapy Management: A Theory-oriented Evaluation. Int J Integr Care. 2019;19(1):1.
Abrahamsen B, Burghle AH, Rossing C. Pharmaceutical care services available in Danish community pharmacies. Int J Clin Pharm. 2020;42(2):315-20.
Babar ZU, Kousar R, Murtaza G, Azhar S, Khan SA, Curley L. Randomized controlled trials covering pharmaceutical care and medicines management: A systematic review of literature. Res Social Adm Pharm. 2018;14(6):521-39.
Ebid AI, Mobarez MA, Ramadan RA, Mahmoud MA. Impact of a Clinical Pharmacist Intervention Program on the Follow-up of Type-2 Diabetic Patients. Hosp Pharm. 2022;57(1):76-82.
Desse TA, Vakil K, Mc Namara K, Manias E. Impact of clinical pharmacy interventions on health and economic outcomes in type 2 diabetes: A systematic review and meta-analysis. Diabetic medicine : a journal of the British Diabetic Association. 2021;38(6):e14526.
Al Haqan AA, Al-Taweel DM, Awad A, Wake DJ. Pharmacists' Attitudes and Role in Diabetes Management in Kuwait. Med Princ Pract. 2017;26(3):273-9.
Wang J, Pei Y, Yu F, Kang Z, Zheng Y. Understandings, Attitudes, and Barriers About Diabetes Care: Analysis of Factors Influencing Community Pharmacists in China. Diabetes Metab Syndr Obes. 2021;14:1999-2009.
El Hajj MS, Abu Yousef SE, Basri MA. Diabetes care in Qatar: a survey of pharmacists' activities, attitudes and knowledge. Int J Clin Pharm. 2018;40(1):84-93.
Douglas E, Power A, Hudson S. Pharmaceutical care of the patient with diabetes mellitus: pharmacists' priorities for services and educational needs in Scotland. International Journal of Pharmacy Practice. 2007;15(1):47-52.
Alzubaidi H, Saidawi W, Mc Namara K. Pharmacist views and pharmacy capacity to deliver professional services in the United Arab Emirates. Int J Clin Pharm. 2018;40(5):1106-15.
Woodhams L, Chalmers L, Hillis GS, Sim TF. Developing community pharmacists' role in the management of type 2 diabetes and related microvascular complications: a nationwide survey in Australia. PeerJ. 2023;11:e14849.
Al Assaf S, Zelko R, Hanko B. The Effect of Interventions Led by Community Pharmacists in Primary Care for Adults with Type 2 Diabetes Mellitus on Therapeutic Adherence and HbA1c Levels: A Systematic Review. International journal of environmental research and public health. 2022;19(10).
Cooney P, Hanley J, Ryan-O'Brien N, Okada H, Bermingham M. The views and experiences of people with type 2 diabetes being cared for by their community pharmacist: a cross-sectional patient survey. J Diabetes Metab Disord. 2022;21(2):1619-24.
Sendekie AK, Tesfaye AH, Tadesse YB, Dagnaw AD, Belachew EA. Actual practices of community pharmacists in the management of diabetes: a comparison of simulated patient-based study with perceived role of involvement. J Pharm Policy Pract. 2024;17(1):2326381.
Kemenkes. Regulation of The Minister of Health of The Republic of Indonesia Number 74 of 2016 on Standards of Pharmaceutical Services In Community Health Centers. In: Department H, editor. Jakarta: Ministry of Health of the Republic of Indonesia; 2016.
Roach M, Land N, Hernandez J, Rau R, Chou JW, Hickson SS, et al. The Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic Diseases. Int J Clin Pract. 2024;2024:5877687.
Ruiz-Ramos J, Hernandez MH, Juanes-Borrego AM, Mila R, Mangues-Bafalluy MA, Mestres C. The Impact of Pharmaceutical Care in Multidisciplinary Teams on Health Outcomes: Systematic Review and Meta-Analysis. J Am Med Dir Assoc. 2021;22(12):2518-26.
Sousa Pinto G, Bader L, Billberg K, Criddle D, Duggan C, El Bizri L, et al. Beating non-communicable diseases in primary health care: The contribution of pharmacists and guidance from FIP to support WHO goals. Res Social Adm Pharm. 2020;16(7):974-7.
Davis CS, Ross LAR, Bloodworth LS. The Impact of Clinical Pharmacist Integration on a Collaborative Interdisciplinary Diabetes Management Team. J Pharm Pract. 2017;30(3):286-90.
Musselman KT, Moczygemba LR, Pierce AL, Plum MF, Brokaw DK, Kelly DL. Development and Implementation of Clinical Pharmacist Services Within an Integrated Medical Group. J Pharm Pract. 2017;30(1):75-81.
Armistead LT, Cruz A, Levitt JM, McClurg MR, Blanchard CM. Medication therapy problem documentation and reporting: A review of the literature and recommendations. Jaccp: Journal of the American College of Clinical Pharmacy. 2021;4(10):1337-47.
Esmalipour R, Salary P, Shojaei A. Trust-building in the Pharmacist-patient Relationship: A Qualitative Study. Iran J Pharm Res. 2021;20(3):20-30.
Belachew EA, Sendekie AK, Wondm SA, Ayele EM, Netere AK. Misunderstanding of dosing regimen instructions among patients with chronic diseases receiving polypharmacy at the University of Gondar comprehensive specialized hospital. PLoS One. 2023;18(1):e0280204.
Manchanayake M, Bandara G, Samaranayake NR. Patients' ability to read and understand dosing instructions of their own medicines - a cross sectional study in a hospital and community pharmacy setting. BMC Health Serv Res. 2018;18(1):425.
Yaghoubi M, Mansell K, Vatanparastc H, Steeves M, Zeng W, Farag M. Effects of Pharmacy-Based Interventions on the Control and Management of Diabetes in Adults: A Systematic Review and Meta-Analysis. Can J Diabetes. 2017;41(6):628-41.
van Heuckelum M, van den Ende CHM, Houterman AEJ, Heemskerk CPM, van Dulmen S, van den Bemt BJF. The effect of electronic monitoring feedback on medication adherence and clinical outcomes: A systematic review. PLoS One. 2017;12(10):e0185453.
Wibowo Y, Parsons R, Sunderland B, Hughes J. An evaluation of community pharmacy-based services for type 2 diabetes in an Indonesian setting: patient survey. PeerJ. 2015;3:e1449.
Moecker R, Terstegen T, Haefeli WE, Seidling HM. The influence of intervention complexity on barriers and facilitators in the implementation of professional pharmacy services - A systematic review. Res Social Adm Pharm. 2021;17(10):1651-62.
Pereira CEO, Bambirra EHF, Fernandes BD, Sousa M, Mendonca SAM, Chemello C. Factors influencing the implementation of pharmaceutical care in outpatient settings: A systematic review applying the Consolidated Framework for Implementation Research. Res Social Adm Pharm. 2022;18(4):2579-92.
Jairoun A, Al-Hemyari S, Shahwan M, Jairoun S, Alorfi N, Zyoud Se, et al. Current Perspectives, Practices, and Barriers Faced by Community Pharmacists Regarding Pharmaceutical Care Services for Diabetes Mellitus in the United Arab Emirates. Journal of Multidisciplinary Healthcare. 2024;Volume 17:2563-76.
Shaya FT, Chirikov VV, Rochester C, Zaghab RW, Kucharski KC. Impact of a comprehensive pharmacist medication-therapy management service. J Med Econ. 2015;18(10):828-37.
Marjadi B, Alfian R, Susanto Y, Tjandra L, Pratama ANW, Schneider C. Pharmacists' continuing professional development for non-communicable diseases management: A consensus study. Res Social Adm Pharm. 2022;18(11):3964-73.
Copyright (c) 2025 Journal of Public Health and Pharmacy
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with Journal of Public Health and Pharmacy retain the copyright of their work. The journal applies a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0), which grants the following rights:
-
Copyright Retention: Authors retain the copyright of their work, maintaining full control over their intellectual property without restrictions.
-
Right of First Publication: Authors grant the journal the right of first publication of their work. This ensures that the work is initially published and credited in Journal of Public Health and Pharmacy.
-
License to Share and Reuse: The work is licensed under CC BY-SA 4.0, allowing others to copy, distribute, remix, and build upon the work for any purpose, even commercially, as long as proper credit is given to the authors, and any new creations are licensed under the same terms.
